Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • News (20)
Videos
Podcast
  • Daily News
  • Conference News
  • Features
  • EAS (5)
  • AHA (1)
  • Clinical Cardiology (19)
  • Prevention (17)
  • Clinical Pharma (16)
  • Lipids (16)
  • Coronary (15)
  • ACS/AMI (10)
  • CAD Pharma (10)
  • Guidelines (9)
  • Approvals (8)
  • Public Health (7)
  • Diabetes (4)
  • Heart Failure (3)
  • Hypertension (3)
  • Heart Failure Pharma (2)
  • Structural Heart (2)
  • Aortic Valve (1)
  • Cath Lab (1)
  • Endovascular (1)
  • Hypertrophic Cardiomyopathy (1)
  • Imaging & Physiology (1)
  • Quality (1)
  • Stroke (1)
  • (-) Policy & Practice (20)
  • 2025 (3)
  • 2024 (1)
  • 2023 (2)
  • 2022 (6)
  • 2021 (2)
  • 2020 (5)
  • 2019 (1)
Displaying 1 - 20 of 20
Sort: Relevancy | Date
Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol
News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan
Michael O'Riordan
August 06, 2025
Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION
News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan
Michael O'Riordan
June 04, 2025
Acoramidis Approved in Europe for ATTR Cardiomyopathy
News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan
Michael O'Riordan
February 12, 2025
Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia
News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan
Michael O'Riordan
May 30, 2024
No Safety Concerns Seen With Inclisiran in Large ORION Analysis
News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan
Michael O'Riordan
December 06, 2023
Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3
News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan
Michael O'Riordan
January 16, 2023
Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?
News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan
Michael O'Riordan
August 15, 2022
Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression
News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan
Michael O'Riordan
August 08, 2022
Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol
News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan
Michael O'Riordan
May 26, 2022
FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses
News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan
Michael O'Riordan
May 26, 2022
ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering
News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan
Michael O'Riordan
May 24, 2022
Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path
News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan
Michael O'Riordan
January 17, 2022
British Medical Groups Express Concern About Inclisiran Rollout
News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan
Michael O'Riordan
December 14, 2021
Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval
News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan
Michael O'Riordan
March 03, 2021
FDA Passes on Inclisiran, Citing Manufacturing Site Problems
News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood
Shelley Wood
December 23, 2020
AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More
News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood
Shelley Wood
December 17, 2020
Inclisiran Approved in Europe for Lowering LDL Cholesterol
News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan
Michael O'Riordan
December 11, 2020
Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention
News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan
Michael O'Riordan
October 08, 2020
Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol
News Daily News

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Yael L. Maxwell
Yael L. Maxwell
January 28, 2020
AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials
News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood
Shelley Wood
November 11, 2019
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2026. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing